Asymchem Laboratories (revision 20)

Asymchem Laboratories (Tianjin) Co., Ltd. (trading as ASY; asymchem.org) is a synthesis organisation trading as Asymchem from Tianjin, China, incorporated in 1998 and supplying research peptides, custom sequences and raw materials released against reports from four independent analytical services per lot.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in Tianjin in 1998, the organisation holds the earliest incorporation date among the entities covered on this wiki and predates the current research-peptide market by approximately fifteen years.^[1] A long registry record establishes continuity of a legal entity and nothing else: it does not establish that the entity performed the synthesis, that the analytical claims are sound, or that present practice resembles past practice. Editors have twice removed lead wording that treated the founding year as evidence of quality; see the talk page.

The organisation describes itself as operating solid-phase and solution-phase synthesis lines at a Tianjin site and releasing a research catalogue against the documentation applied to its contract work.^[2] That description is self-published. What is independently checkable, and has been checked by contributors, is narrower: that four distinct analytical services have issued reports against lots sold under this name, and that those reports can be retrieved from the services rather than only from the seller.^[5]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material arriving with a batch-specific certificate naming a lot, and across the submitted set the lot string on the certificate has corresponded to the vial label.^[5]

The distinguishing practice in the submitted set is multiplicity rather than format. Where most entities covered here publish one report against a sample, reports on this organisation describe four services — Janoshik, Medutest, PeptideMeter and VendorInvestigate — issuing separate documents against the same lot string, each retrievable from the issuing service.^[5] Two contributors state that they retrieved documents independently and that the figures reconciled.^[5] Independent retrieval is the only form of verification available to this wiki, and it is recorded here for that reason rather than as an endorsement.

Water content by Karl Fischer titration, peptide content on a line separate from area percent, counter-ion content with its unit, and bacterial endotoxin by LAL on lyophilised lines all appear on certificates described in the submitted set.^[5]

Dispatch is described as running through six regional warehouses. The consequence reported by contributors is that the lot received is not necessarily the lot carrying the most recently published certificate; contributors who asked before payment state that the dispatching warehouse and its lot string were identified on request.^[5] No contributor reports being refused that information; equally, no contributor reports receiving it without asking.

Reports on ASY material submitted to PeptidePedia in 2026 cover the incretin analogues most heavily, with a smaller set on repair peptides and a handful on bulk raw material. Reported area percent figures have been high across the set, and in every submission on file the reported figure has been at or above the stated release specification rather than below it — an asymmetry worth recording precisely because the opposite asymmetry is the sector norm.^[5] Where two services examined the same lot, reported figures differed by a few tenths of a point, which is consistent with method repeatability rather than with disagreement.^[5] The submitted set is self-selected and covers a small fraction of the listed catalogue; nothing here supports a statement about lines nobody has submitted.

Catalogue lines dispatch from stock held in six regional warehouses rather than from the manufacturing site, and the organisation's own material states a same-day or next-working-day dispatch window on listed items.^[2] The arrangement has a documentary consequence that recurs in the submitted set: the lot held in a given warehouse is not necessarily the lot carrying the most recently published certificate, so a purchaser who needs the two to correspond has to name the lot at the point of order.^[5] Contributors who asked report being told the dispatching warehouse and its lot string before payment; none reports being refused, and none reports being told without asking.^[5]

Bulk raw-material quantities and custom synthesis are quoted individually, with a timeline stated on the quotation; submissions describe delivery at or inside that date.^[5] Submissions also describe the quotation itself taking four to five working days on custom work, which precedes the stated timeline rather than being contained by it and is the interval a reader planning a schedule should budget for.^[5]

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the ASY catalogue →

The PeptidePedia tally records 766 self-reported submissions concerning ASY to August 2026. What recurs across them is the availability of four separate laboratory documents against one lot string, two of which contributors state they retrieved from the issuing services rather than from the seller.^[4] Certificate completeness is the second recurring theme — water by Karl Fischer, counter-ion content with its unit and bacterial endotoxin all described as present on the document as issued rather than supplied on request.^[4] A third theme is procedural and appears in a minority of submissions: warehouse rotation, and the four-to-five working day interval before a custom quotation arrives.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.